Health News

Arizona's medical marijuana program saw an increase in patient count in the month of September 2019, while combined retail sales volume of medical marijuana in the state declined from the prior month. According to monthly data released by the Arizona Department of Health Services or ADHS, Arizona's...
Read More

Interstitial Cystitis Drug Linked To Retinal Damage: Study

Elmiron, the only FDA-approved oral drug to treat interstitial cystitis, also known as bladder pain syndrome, has been found to be associated with a vision-threatening eye condition, according to a new study.
Read More

No Piggy Tale: Some Brain Functions Restored Even Hours After Death

The conventional wisdom is that if the brain cells of humans and other mammals are deprived of oxygen for 4-5 min, they begin to die, and that the loss of brain functions after death is irreversible. But the findings of a study conducted by Yale University researchers challenge these long-held assumptions.
Read More
bornbaby-sept30.jpgA recent study, done by researchers from the Wellcome Sanger Institute, UCL, the University of Birmingham and their collaborators, found that there is a difference in the gut bacteria of babies delivered vaginally and those born via caesarean.
Read More
Follow RTT

FDA Calendar
Event DateSymbolDrug NameEvent Name
12/28/19AMRN Vascepa (sNDA)FDA decision on expansion of Vascepa labeling based on the REDUCE-IT cardiovascular outcomes study.
12/27/19ITCILumateperone (NDA)FDA decision on Lumateperone for the treatment of schizophrenia
12/27/19DRRXPOSIMIR (Resubmitted NDA)FDA decision on POSIMIR for post-operative pain relief depot product
12/25/19ALKSVumerity (diroximel fumarate) (NDA)FDA decision on diroximel fumarate for Relapsing Remitting Multiple Sclerosis
12/15/19AVDLAV001 (NDA)FDA decision on AV001 for Hospital product
12/04/19XLRNLuspatercept (BLA)FDA decision on Luspatercept for adult patients with beta-thalassemia-associated anemia
View All